Shao-Lee Lin's Net Worth
$17.9 Million
Who is Shao-Lee Lin?
Shao-Lee Lin has an estimated net worth of $17.9 Million. This is based on reported shares across multiple companies, which include Horizon Pharma plc, Surrozen, Inc./DE, Principia Biopharma Inc., Third Harmonic Bio, Inc., and ACELYRIN, Inc..
SEC CIK
Shao-Lee Lin's CIK is 0001725092
Past Insider Trading and Trends
2020 was Shao-Lee Lin's most active year for acquiring shares with 7 total transactions. Shao-Lee Lin's most active month to acquire stocks was the month of December. 2020 was Shao-Lee Lin's most active year for disposing of shares, totalling 9 transactions. Shao-Lee Lin's most active month to dispose stocks was the month of December. 2023 saw Shao-Lee Lin paying a total of $0.00 for 3,519,189 shares, this is the most they've acquired in one year. In 2023 Shao-Lee Lin cashed out on 2,219,180 shares for a total of $8,324,949.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Pharma plc No price found
EVP, Head R&D and CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.21% | 3.41K |
$38.25 | -$103,887.00 | 109.67K |
Jan 21
| |||
Form 4
| +118.72% | 57.67K |
$36.10 | -$1,668,289.30 | 106.25K |
Jan 3 - Jan 5
| |||
Form 4
| +71.75% | 19.86K |
$21.54 | -$340,224.30 | 47.53K |
Feb 20
| |||
Form 4
|
∞
| 27.67K |
$20.39 | -$460,385.81 | 27.67K |
Jan 4 - Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surrozen, Inc./DE (SRZN) Snapshot price: $9.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Third Harmonic Bio, Inc. (THRD) Snapshot price: $12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.63% | -9.96K |
$6.63 | -$66,024.50 | 1.58M |
Apr 1
| |||
Form 4
| -0.98% | -15.70K |
$7.60 | -$119,402.96 | 1.59M |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
| -0.66% | -10.69K |
$7.41 | -$79,188.24 | 1.6M |
Jan 2
| |||
Form 4
| -67.88% | -1.03M |
—
|
—
| 487.2K |
Oct 4
| |||
Form 4
| +109.40% | 842.4K |
—
|
—
| 1.61M |
Aug 16
| |||
Form 4
| +28.93% | 824.57K |
$24.69 | -$8,324,949.51 | 3.67M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||